glp 1 agonists review Glucagon‐like peptide agonists: A prospective - Mariam - 2024 - Endocrinology, Diabetes & Metabolism Mechanisms by which GLP-1 agonists

These symptoms make sense biologically, based on how GLP-1 drugs can engage and modulate dopamine-producing neurons in the brains ventral tegmental area (VTA), a region that influences peoples moment-to-moment motivation for motor, cognitive, and complex executive behavior, the doctors wrote

Adding complementary peptides: Orforglipron addresses appetite and glycemic control but doesn't directly target body composition optimization, tissue repair, energy production, or other health dimensions

Considering this evidence, increasing neurogenesis in the brain through the GLP-1 pathway may provide a novel approach for improving depressive-like behavior in patients with depression

Moderate aerobic exercise performed 30 to 60 minutes after a meal enhances postprandial GLP-1 response compared to sedentary behavior

doi: 10.1078/0944-7113-00081 261 RituMNandiniJ

The Promise of GLP-1 Drugs: More Than Just Diabetes Management When GLP-1 (Glucagon-Like Peptide-1) receptor agonists first hit the market, they were hailed as a breakthrough in type 2 diabetes